Evidence map›Paper›PMID 29311641›Full record

ArticleScientific reports2018

Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.

Li-Hsin Chang, Hui-Ching Lin, Shiang-Suo Huang, I-Chih Chen, Kai-Wen Chu, Chun-Lien Chih, Yao-Wen Liang, Yi-Chung Lee, You-Yin Chen, Yi-Hsuan Lee and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Soluble Epoxide Hydrolase and Diabetes Complications.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Li-Hsin ChangInstitute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Hui-Ching LinDepartment and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan.
Shiang-Suo HuangDepartment of Pharmacology, Institute of Medicine, Chung-Shan Medical University, Taichung, Taiwan.
I-Chih ChenInstitute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Kai-Wen ChuDepartment and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan.
Chun-Lien ChihCheng Hsin General Hospital, Taipei, Taiwan.
Yao-Wen LiangDepartment of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan, Taipei, Taiwan.
Yi-Chung LeeDepartment of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan.
You-Yin ChenDepartment of BioMedical Engineering, National Yang-Ming University, Taipei, Taiwan.
Yi-Hsuan LeeDepartment and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan.
I-Hui LeeInstitute of Brain Science, National Yang-Ming University, Taipei, Taiwan. ihlee@vghtpe.gov.tw.ORCID http://orcid.org/0000-0002-5344-6685
National Yang Ming Chiao Tung University · TWCheng Hsin General Hospital · TWChung Shan Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition and deletion of soluble epoxide hydrolase (sEH) has been suggested to ameliorate infarction in experimental ischemic stroke possibly via vasoactive epoxyeicosatrienoic acids. However, it is unknown whether the neuroprotective mechanisms involve alteration of post-ischemic neuronal transmission and neurotrophic signaling. We used a permanent middle cerebral artery occlusion (MCAO) model in adult wild-type mice with the sEH inhibitor 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA) post-treatment and in sEH knockout (sEH KO) mice. We found that sensorimotor recovery was significantly enhanced after MCAO in both AUDA-treated and sEH KO mice, with decreased sEH activity and brain infarction. Decreased post-ischemic long-term potentiation (iLTP) was observed in an ex vivo hippocampal oxygen-glucose deprivation model. Tropomyosin receptor kinase B (TrkB) activation, rather than glutamate receptor alteration, was consistently found after the different manipulations. Immunohistochemistry further revealed peri-infarct neuronal TrkB activation and microvasculature augmentation in AUDA-treated and sEH KO mice, suggesting parallel neurovascular enhancement. Mechanistically, pretreatment with a selective TrkB antagonist ANA12 countered the effect of iLTP attenuation induced by sEH deletion ex vivo and abolished the infarct reduction in vivo. Together, the neuroprotective effects of sEH inhibition and gene deletion can both be mediated partially via enhancement of TrkB signaling which attenuated post-ischemic neuroexcitation and neurological deficits.

Indexed as

Excitatory Postsynaptic PotentialsAnimalsCerebral CortexDisease Models, AnimalEnzyme ActivationEpoxide HydrolasesGene DeletionHippocampusMaleMembrane GlycoproteinsMiceMice, KnockoutMotor ActivityNeuronsNeuroprotective AgentsProtein-Tyrosine KinasesEpoxide HydrolasesMembrane GlycoproteinsNeuroprotective AgentsNtrk2 protein, mouseProtein-Tyrosine KinasesReceptor, trkB

Identifiers

PMID29311641
PMCPMC5758800
OpenAlexW2782160756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.